RYSTIGGO
NDC 50474-982 · UCB, Inc.
Generic nameROZANOLIXIZUMAB
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)ROZANOLIXIZUMAB
Strength140 mg/mL
Pharmacologic classNeonatal Fc Receptor Blocker [EPC], Neonatal Fc Receptor Blockers [MoA]
Marketing categoryBLA
Packages
50474-982-84 — 1 VIAL, GLASS in 1 CARTON (50474-982-84) / 4 mL in 1 VIAL, GLASS
Billed under HCPCS
J9333 — Injection, rozanolixizumab-noli, 1 mg Medicare Part B payment limit (ASP + 6%): $23.59
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
50474-980 — ROZANOLIXIZUMAB, 50474-981 — ROZANOLIXIZUMAB, 50474-983 — ROZANOLIXIZUMAB